Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
申请人:Anikin Alexey Vyacheslavovich
公开号:US20080207635A1
公开(公告)日:2008-08-28
The present invention provides compounds capable of modulating tyrosine kinases, compositions comprising the compounds and methods of their use.
本发明提供了能够调节酪氨酸激酶的化合物,包括这些化合物的组合物和使用它们的方法。
Heterocyclic compounds as TrkA modulators
申请人:ChemBridge Corporation
公开号:EP2298770A1
公开(公告)日:2011-03-23
The present invention provides compounds capable of modulating tyrosine kinases, compositions comprising the compounds and methods of their use.
本发明提供了能够调节酪氨酸激酶的化合物、包含这些化合物的组合物及其使用方法。
US8629147B2
申请人:——
公开号:US8629147B2
公开(公告)日:2014-01-14
Synthesis of novel substituted spirohydantoins
作者:George M. Carrera、David S. Garvey
DOI:10.1002/jhet.5570290430
日期:1992.7
The synthesis of novel N-1-alkylspirohydantoins (1-alkyl-1,3,8-triazaspiro[4.5]decanes) is reported. The key hydantoin intermediates 3 were prepared using standard hydantoin methodology. This synthesis allows for differential substitution of all three nitrogens.